Addus HomeCare (ADUS) Set to Announce Earnings on Monday

Addus HomeCare (NASDAQ:ADUS) will be posting its quarterly earnings results after the market closes on Monday, November 4th. Analysts expect Addus HomeCare to post earnings of $1.14 per share for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so using this link.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings results on Monday, August 5th. The company reported $1.35 earnings per share for the quarter, beating the consensus estimate of $1.21 by $0.14. The company had revenue of $286.90 million during the quarter, compared to analyst estimates of $284.90 million. Addus HomeCare had a net margin of 6.18% and a return on equity of 9.81%. The firm’s revenue for the quarter was up 10.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.94 earnings per share. On average, analysts expect Addus HomeCare to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Addus HomeCare Stock Performance

ADUS opened at $126.27 on Friday. The firm has a market cap of $2.29 billion, a P/E ratio of 29.92, a PEG ratio of 2.28 and a beta of 1.04. The firm has a 50-day moving average of $130.02 and a 200 day moving average of $120.10. Addus HomeCare has a fifty-two week low of $80.68 and a fifty-two week high of $136.12.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the stock. Stephens reaffirmed an “overweight” rating and set a $138.00 price objective on shares of Addus HomeCare in a report on Tuesday, August 6th. KeyCorp assumed coverage on shares of Addus HomeCare in a report on Friday, October 11th. They set an “overweight” rating and a $150.00 price objective on the stock. Royal Bank of Canada reaffirmed an “outperform” rating and set a $141.00 price objective on shares of Addus HomeCare in a report on Tuesday, September 3rd. Macquarie reaffirmed an “outperform” rating and set a $139.00 price objective on shares of Addus HomeCare in a report on Friday, October 11th. Finally, Oppenheimer upped their price objective on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a report on Monday, September 23rd. One research analyst has rated the stock with a sell rating, eight have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $131.38.

Insider Transactions at Addus HomeCare

In other news, Director Esteban Lopez sold 500 shares of the stock in a transaction dated Wednesday, September 4th. The shares were sold at an average price of $130.03, for a total value of $65,015.00. Following the sale, the director now directly owns 3,866 shares of the company’s stock, valued at approximately $502,695.98. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In related news, Director Esteban Lopez sold 500 shares of the firm’s stock in a transaction that occurred on Wednesday, September 4th. The shares were sold at an average price of $130.03, for a total value of $65,015.00. Following the sale, the director now directly owns 3,866 shares of the company’s stock, valued at $502,695.98. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the completion of the sale, the executive vice president now directly owns 7,215 shares in the company, valued at $961,687.35. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 22,917 shares of company stock valued at $3,050,082. 4.60% of the stock is currently owned by corporate insiders.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.